首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Stem Cells-Derived Extracellular Vesicles: Potential Therapeutics for Wound Healing in Chronic Inflammatory Skin Diseases
【2h】

Stem Cells-Derived Extracellular Vesicles: Potential Therapeutics for Wound Healing in Chronic Inflammatory Skin Diseases

机译:干细胞衍生的细胞外囊泡:慢性炎症皮肤病中伤口愈合的潜在治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endosome-derived small extracellular vesicles (EVs), often referred to as exosomes, are produced by almost all, if not all, cell types, and are critical for intercellular communication. They are composed of a lipid bilayer associated with membrane proteins and contain a payload of lipids, proteins and regulatory RNAs that depends on the parental cell physiological condition. By transferring their “cargo”, exosomes can modulate the phenotype of neighboring and distant cells. Stem cells (SC) were widely studied for therapeutic applications regarding their regenerative/reparative potential as well as their immunomodulatory properties. Whether from autologous or allogeneic source, SC beneficial effects in terms of repair and regeneration are largely attributed to their paracrine signaling notably through secreted EVs. Subsequently, SC-derived EVs have been investigated for the treatment of various diseases, including inflammatory skin disorders, and are today fast-track cell-free tools for regenerative/reparative strategies. Yet, their clinical application is still facing considerable challenges, including production and isolation procedures, and optimal cell source. Within the emerging concept of “allogeneic-driven benefit” for SC-based therapies, the use of EVs from allogeneic sources becomes the pragmatic choice although a universal allogeneic cell source is still needed. As a unique temporary organ that ensures the mutual coexistence of two allogeneic organisms, mother and fetus, the human placenta offers a persuasive allogeneic stem cell source for development of therapeutic EVs. Advancing cell-free therapeutics nurtures great hope and provides new perspectives for the development of safe and effective treatment in regenerative/reparative medicine and beyond. We will outline the current state of the art in regard of EVs, summarize their therapeutic potential in the context of skin inflammatory disorders, and discuss their translational advantages and hurdles.
机译:内体衍生的小细胞外囊泡(EVS)通常被称为外来体,几乎是全部,如果不是全部,细胞类型,并且对于细胞间通信至关重要。它们由与膜蛋白相关的脂质双层组成,含有脂质,蛋白质和调节RNA的有效载荷,其取决于亲本细胞生理病症。通过转移“货物”,外来物可以调节相邻和远处细胞的表型。对干细胞(SC)被广泛研究了关于其再生/修复潜力以及其免疫调节性能的治疗应用。无论是来自自体或同种异体源,在修复和再生方面的SC有益效果都很大程度上归因于其帕拉卡碱基通过分泌的EVS表示。随后,已经研究了SC-衍生的EVS用于治疗各种疾病,包括炎症性皮肤疾病,并且是今天的快速轨道无细胞工具,用于再生/重复策略。然而,他们的临床应用仍然面临着相当大的挑战,包括生产和隔离程序和最佳的细胞来源。在基于SC的疗法的“同种异体驱动益处”的新兴概念中,尽管仍然需要普遍的同种异体细胞来源,但来自同种异体来源的EVS的使用成为语用选择。作为一种独特的临时器官,可确保两种同种异体生物,母亲和胎儿的互相共存,人类胎盘为治疗性EV的发育提供了有说服力的同种异体干细胞来源。推进无细胞的治疗方法培养大希望,并为在再生/批准医学和超越中,为安全有效的治疗提供了新的观点。我们将概述现有技术在EVS方面,总结其在皮肤炎症障碍的背景下的治疗潜力,并讨论其平移优势和障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号